GlassScriptPhysician profile
Bradley Peltzer
NPI 1275976813
$12,510.92
in general payments reported to CMS, 2019-2025
20 companies · $986 in 2025
The $986 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,970 · 2022: $3,898 · 2023: $957 · 2024: $699 · 2025: $986.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,543 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,543.03 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $6,933.41 | 2021-2022 | |
| Boston Scientific Corporation | $2,672.14 | 2021-2025 | General - Therapies, Resonate El Icd Vr, Lux-Dx Insertable Cardiac Monitor |
| Biosense Webster, INC. | $1,102.86 | 2021-2024 | Carto 3 |
| Medtronic, INC. | $473.84 | 2021-2023 | Claria Mri Quad Crt-D Surescan, N/A |
| Ebr Systems, INC. | $302.95 | 2025 | |
| Atricure, INC. | $209.08 | 2021-2023 | |
| Abbott Laboratories | $180.78 | 2021-2025 | Perclose Prostyle |
| Astrazeneca Pharmaceuticals LP | $134.78 | 2023 | Andexxa, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $132.16 | 2022-2023 | Lifevest |
| Terumo Medical Corporation | $111.33 | 2021-2023 | Glidewire, Heartrail |
| Pfizer INC. | $59.29 | 2022-2023 | |
| Impulse Dynamics (USA) INC. | $36.59 | 2023 | Optimizer |
| Janssen Pharmaceuticals, INC | $31.43 | 2021 | |
| Amgen INC. | $28.31 | 2023 | Repatha |
| Merck Sharp & Dohme LLC | $27.00 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Altathera Pharmaceuticals LLC | $17.48 | 2022 | |
| Sanofi-Aventis U.S. LLC | $14.92 | 2022 | |
| Esperion Therapeutics, INC. | $14.57 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.49 | 2021 | |
| Angiodynamics, INC. | $13.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Peltzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.